Profile
| Metric | Value |
|---|---|
| Full Name | Privia Health Group, Inc. |
| Ticker | NASDAQ: PRVA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | priviahealth.com |
| Employees | 1,140 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $24.42 | |
| Price, 1D Change | +1.16% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | 171.97 | |
| Beta | 0.55 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +4.74% | |
| EPS | $0.11 | |
| EPS, 1Y Change | -38.14% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.11 | |
| EPS Estimate | $0.94 | |
| EPS Est. Change | +724.63% | |
| Revenue | $1.74B | |
| Revenue Estimate | $2.10B | |
| Revenue Est. Change | +20.81% | |
| Current Price | $24.42 | |
| Price Target | - | $31.00 |
| Price Tgt. Change | - | +26.95% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.21 | $0.19 | -11.86% | |
| $0.77 | $0.11 | -85.13% | |
| $0.94 | N/A | +724.63% | |
| $1.05 | N/A | +818.86% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.81B | $1.66B | -41.09% | |
| $1.70B | $1.74B | +2.38% | |
| $2.10B | N/A | +20.81% | |
| $2.31B | N/A | +33.08% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +20.59% | |
| Price, 3Y | +13.53% | |
| Market Cap, 1Y | +23.29% | |
| Market Cap, 3Y | +21.76% | |
| Revenue, 1Y | +4.74% | |
| Revenue, 3Y | +79.71% | |
| EPS, 1Y | -38.14% | |
| EPS, 3Y | +106.56% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $24.42 | |
| SMA 200 | $23.02 | |
| SMA 200 vs Price | -5.74% | |
| SMA 50 | $24.12 | |
| SMA 50 vs Price | -1.24% | |
| Beta | 0.55 | |
| ATR | $0.65 | |
| 14-Day RSI | 55.58 | |
| 10-Day Volatility | 23.02% | |
| 1-Year Volatility | 31.62% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.74B | |
| EPS | $0.11 | |
| Gross Profit | $176.85M | |
| Gross Margin | 10.19% | |
| Operating Profit | $16.98M | |
| Operating Margin | 0.98% | |
| Net Income | $17.04M | |
| Net Margin | 0.83% | |
| EBITDA | $24.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.01 | |
| Current Ratio | 1.86 | |
| Quick Ratio | 1.86 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 5.65 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 171.97 | |
| PS Ratio | 1.47 | |
| PB Ratio | 4.24 | |
| EV/EBITDA | 68.89 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $635.18M | |
| Cash & Equivalents | $491.15M | |
| Total Assets | $1.15B | |
| Current Assets | $834.82M | |
| Total Liabilities | $462.33M | |
| Current Liabilities | $449.15M | |
| Total Debt | $5.59M | |
| Short Term Debt | $2.55M | |
| Accounts Payable | $374.36M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.72B | |
| Operating Expenses | $159.87M | |
| Cost Of Goods Sold | $1.56B | |
| SG&A | $152.60M | |
| D&A | $7.27M | |
| Interest Expense | $0.00 | |
| Income Tax | $10.83M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $109.28M | |
| CFI | -$11.98M | |
| CFF | $4.33M | |
| Capex | $5.02M | |
| Free Cash Flow | $109.28M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Stephens & Co. | → | |
| JP Morgan | → | |
| BMO Capital | ||
| Canaccord Genuity | → | |
| Truist Securities | → | |
| Barclays | → | |
| Evercore ISI Group | → | |
| Citizens | → | |
| Barclays | → | |
| Stephens & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with PRVA
Data Sources & References
- PRVA Official Website www.priviahealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1759655/000175965525000110/0001759655-25-000110-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1759655/000175965525000018/0001759655-25-000018-index.htm
- PRVA Profile on Yahoo Finance finance.yahoo.com/quote/PRVA
- PRVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/prva
FAQ
What is the ticker symbol for Privia Health Group, Inc.?
The ticker symbol for Privia Health Group, Inc. is NASDAQ:PRVA
Does Privia Health Group, Inc. pay dividends?
No, Privia Health Group, Inc. does not pay dividends
What sector is Privia Health Group, Inc. in?
Privia Health Group, Inc. is in the Healthcare sector
What industry is Privia Health Group, Inc. in?
Privia Health Group, Inc. is in the Health Information Services industry
What country is Privia Health Group, Inc. based in?
Privia Health Group, Inc. is headquartered in United States
When did Privia Health Group, Inc. go public?
Privia Health Group, Inc. initial public offering (IPO) was on April 28, 2021
Is Privia Health Group, Inc. in the S&P 500?
No, Privia Health Group, Inc. is not included in the S&P 500 index
Is Privia Health Group, Inc. in the NASDAQ 100?
No, Privia Health Group, Inc. is not included in the NASDAQ 100 index
Is Privia Health Group, Inc. in the Dow Jones?
No, Privia Health Group, Inc. is not included in the Dow Jones index
When was Privia Health Group, Inc. last earnings report?
Privia Health Group, Inc.'s most recent earnings report was on November 6, 2025
When does Privia Health Group, Inc. report earnings?
The next expected earnings date for Privia Health Group, Inc. is February 26, 2026
